Another fantastic result, that opens another dimension for Clarity's diagnostic suite.
AT: "Copper-64 has comparably low radiation doses to currently used isotopes and involves similar management of patients. However, the longer half-life of copper-64 of 12.7 hours, combined with Clarity’s proprietary position in copper-based theranostics, now sets up a foundation for a complete suite of next-generation radiodiagnostics, which could be unmatched in the radiopharmaceutical sector. The opportunity for centralised, multi-layer manufacturing and broad distribution means that every patient with access to PET imaging can potentially have optimal cancer diagnostic care, not limited by isotope half-life."
CU6 Price at posting:
$6.16 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)